{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-052586","form_type":"8-K","ticker":"BXC","cik":"0001301787","company_name":"BlueLinx Holdings Inc.","filed_at":"2026-08-04T20:14:33+00:00","discovered_at":"2026-08-04T20:16:00.346305+00:00","generated_at":"2026-08-04T20:16:24.106849+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BlueLinx Q2 net sales up 4.4% to $814M; adjusted EPS $1.15 vs $0.70 YoY","bullets":["Net sales $814M (+4.4% YoY); gross margin 17.2% (up 190 bps) including $7.2M import duty benefit.","Net income $6.4M ($0.81 diluted EPS); adjusted net income $9.1M ($1.15 adjusted diluted EPS), up 62% and 64% YoY.","Adjusted EBITDA $36M (4.4% of sales), up 33% YoY; free cash flow $9M, improvement of $45M.","Specialty products sales $564M (+3.8%), structural $250M (+5.6%); both segments saw margin expansion.","Q3 outlook: specialty gross margin 18-19%, structural 8.5-9.5%; expects higher daily sales volumes YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-052586","json":"https://secwatch.observer/filing/0001628280-26-052586.json","markdown":"https://secwatch.observer/filing/0001628280-26-052586.md","text":"https://secwatch.observer/filing/0001628280-26-052586.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1301787/000162828026052586/0001628280-26-052586-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1301787/000162828026052586/bxc-20260804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T20:16:24.106849+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}